LXEO — Lexeo Therapeutics, Inc. Common Stock stock price, charts and financials

QT40Lexeo Therapeutics, Inc. Common Stock

Lexeo Therapeutics, Inc. Common Stock (NASDAQ: LXEO) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
4.63
-0.18-3.74%
OverviewShort InterestFilings
LXEOQT40Lexeo Therapeutics, Inc. Common Stock·NASDAQ
4.63-3.74%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20268-KCurrent report
Jun 29, 20264Statement of changes in beneficial ownership
Jun 15, 20268-KCurrent report
May 20, 20264Statement of changes in beneficial ownership
May 20, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 11, 20268-KCurrent report
May 11, 202610-QQuarterly report
Apr 30, 20268-KCurrent report
Apr 30, 2026DEFA14AAdditional proxy soliciting materials
Apr 30, 2026ARSAnnual report to shareholders
Apr 30, 20263Initial statement of beneficial ownership
Apr 30, 20264Statement of changes in beneficial ownership
#1 / 25 of 296
Page
▼
/ 12